ESC 365 - Panel discussion / Q&A - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.

ESC Premium Access

Panel discussion / Q&A - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.

Session: Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations

Topic: Lipids

Speaker: Doctor C. Gibson (Boston, US) Professor W. Koenig (Munich, DE) Professor J. Jukema (Leiden, NL)

Sponsored by Pfizer, Inc.

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speakers

Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)

16 presentations

2 followers

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)

24 presentations

0 follower

Professor J Wouter Jukema

Leiden University Medical Center, Leiden (Netherlands (The))

22 presentations

2 followers

3 more presentations in this session

Welcome and introductions - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.

Speaker: Doctor C. Gibson (Boston, US)

Beyond statins: understanding unmet need across the CV risk continuum.

Speaker: Professor W. Koenig (Munich, DE)

Current challenges in CV risk reduction for high-risk primary and secondary prevention populations.

Speaker: Professor J. Jukema (Leiden, NL) Doctor C. Gibson (Boston, US)

Access the full session

Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations

Speakers: Doctor C. Gibson, Professor W. Koenig, Professor J. Jukema, Doctor C. Gibson, Professor W. Koenig...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources